首页> 外文期刊>Public health reviews >From Framingham to North Karelia to U.S. Community-Based Prevention Programs: Negotiating Research Agenda for Coronary Heart Disease in the Second Half of the 20th Century
【24h】

From Framingham to North Karelia to U.S. Community-Based Prevention Programs: Negotiating Research Agenda for Coronary Heart Disease in the Second Half of the 20th Century

机译:从弗雷明汉(Framingham)到北卡累利阿(North Karelia)到美国基于社区的预防计划:20世纪下半叶关于冠心病的研究议程谈判

获取原文
       

摘要

In the United States in 1948, the newly formed National Heart Institute (NHI) responded to what its data showed as a rising tide of coronary heart disease (CHD) by underwriting new approaches to the elucidation of chronic disorders. In the process, it funded the application of epidemiology, previously almost exclusively concerned with communicable disease, to study CHD. With federal encouragement, CHD epidemiologists enriched research designs, helped develop the randomized controlled trial, and played a pioneering role in chronic disease prevention at the individual and population levels. While government funding was critical to the evolution of this rich scientific work, a vibrant epidemiological imagination was able to capitalize on decades of national political commitment to chronic disease research. Epidemiologists developed longitudinal studies meant to determine the relationship between well-measured clinical variables and subsequent CHD events. Here, consistent associations within and across populations, eventually reinforced by analyses of pooled data from multiple cohort investigations, demonstrated the existence of well-founded risk factors, but left open the question of causal inference based on observed relationships. After substantial ambivalence, the U.S. government, under pressure from epidemiologists, committed to an agenda of clinical trials to test that proposition. In addition, the results of the cohort studies elicited a demand by epidemiologists for a broader, population-wide approach, testing whether community-level models of risk factor modification through broad cultural change would demonstrate a reduction in the probability of disability and premature death from heart attack.To tell the story of the community studies and to analyze outcomes, we focus on the Minnesota Heart Health Program and the Finnish North Karelia Project. From the North Karelia experience, we find that health promotion campaigns in communities at very high risk of disease, where the population lives in traditional patterns and considerable poverty and is also unsophisticated in health knowledge and behaviors, are more likely to achieve major and measurable population effects. We argue that as chronic disease rates rise globally, and CHD rates increase in lower- and middle-income nations, as they have over the past several decades, population-level prevention interventions have become particularly relevant. But it remains to be seen whether the international community, prodded by its member states, can successfully reproduce the urgency and agenda-setting that sparked the successful epidemiologic and public health interventions in the affluent countries in the decades after World War II.
机译:1948年在美国,新成立的国家心脏研究所(NHI)通过制定新的方法来阐明慢性病,从而回应了其数据显示的冠心病(CHD)上升趋势。在此过程中,它资助了以前几乎仅涉及传染病的流行病学研究冠心病的应用。在联邦的鼓励下,冠心病流行病学家丰富了研究设计,帮助开展了随机对照试验,并在个人和人群的慢性疾病预防中发挥了先锋作用。尽管政府的资金对于这项丰富的科学工作的发展至关重要,但充满活力的流行病学想象力却可以利用数十年来对慢性病研究的国家政治承诺。流行病学家开展了纵向研究,旨在确定测量良好的临床变量与随后的冠心病事件之间的关系。在这里,人群内部和人群之间的一致关联,最终通过多次队列研究汇总数据的分析得到了加强,证明了存在有充分根据的风险因素,但根据观察到的关系却没有因果推理的问题。经过明显的矛盾之后,美国政府在流行病学家的压力下,致力于临床试验议程,以检验这一主张。此外,队列研究的结果引发了流行病学家对更广泛的人群范围内方法的需求,该方法测试通过广泛的文化变革而在社区一级对风险因素进行修正的模型是否会证明残疾和因过早死亡而减少的可能性为了讲述社区研究的故事并分析结果,我们重点关注明尼苏达州心脏健康计划和芬兰北卡累利阿项目。从北卡累利阿的经验中,我们发现在疾病风险很高的社区中开展健康促进运动的可能性更大,这些社区的人口以传统方式生活并且生活在相当贫困的状态,并且对健康知识和行为的理解不高,效果。我们认为,随着全球慢性病发病率上升,以及中低收入国家的冠心病发病率上升,就像过去几十年一样,人口一级的预防干预措施变得尤为重要。但是,有待国际社会在其成员国的推动下能否成功地再现紧迫性和议程设定,从而引发第二次世界大战后几十年中富裕国家成功进行流行病学和公共卫生干预。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号